Skip to main content
Clinical Trials/JPRN-UMIN000018388
JPRN-UMIN000018388
Recruiting
Phase 2

Prospective Evaluation of the Molecular Effects of Itraconazoleas an anti-cancer agent: A Window of Opportunity Study - A window study of itraconazole

Hyogo College of Medicine0 sites20 target enrollmentAugust 10, 2015
Conditionssolid tumors

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
solid tumors
Sponsor
Hyogo College of Medicine
Enrollment
20
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 10, 2015
End Date
July 31, 2026
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Uncontrolled bowel obstruction, history of allergic reactions attributed to itraconazole, current use of medications significantly affecting metabolism of itraconazole, pregnant or lactating female.

Outcomes

Primary Outcomes

Not specified

Similar Trials